Side Effects of alpha-Blocker Use: Retrograde Ejaculation. (Q55052564)

PubMed publication ID

20126607

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20126607%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Side Effects of alpha-Blocker Use: Retrograde Ejaculation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2812888&resulttype=core&format=json

7 May 2020

1

Steven A Kaplan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2812888&resulttype=core&format=json

7 May 2020

publication date

1 January 2009

1 reference

PubMed publication ID

20126607

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20126607%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2812888&resulttype=core&format=json

7 May 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2812888&resulttype=core&format=json

7 May 2020

issue

Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2812888&resulttype=core&format=json

7 May 2020

page(s)

S14-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2812888&resulttype=core&format=json

Alpha1-adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213)

7 May 2020

cites work

1 reference

12 December 2020

Long-term, open-label, phase III multicenter study of tamsulosin in benign prostatic hyperplasia

1 reference

12 December 2020

Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia

1 reference

12 December 2020

Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men.

1 reference

12 December 2020

Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies

1 reference

12 December 2020

Tamsulosin for benign prostatic hyperplasia.

1 reference

12 December 2020

Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction

1 reference

12 December 2020

Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results.

1 reference

12 December 2020

Alpha1-adrenoceptors and ejaculatory function

1 reference

12 December 2020

Relative importance of sexuality and quality of life in patients with prostatic symptoms. Results of an international study.

1 reference

12 December 2020

Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction

1 reference

12 December 2020

Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study

1 reference

12 December 2020

Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial. Tamsulosin Investigator Group

1 reference

12 December 2020

Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia

1 reference

12 December 2020

Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system

1 reference

12 December 2020

Effects of Acute Treatment With Tamsulosin Versus Alfuzosin on Ejaculatory Function in Normal Volunteers

1 reference

12 December 2020

Overview of alpha-blocker therapy for benign prostatic hyperplasia

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2812888&resulttype=core&format=json

7 May 2020

PubMed publication ID

20126607

1 reference